BIOCRYST PHARMACEUTICALS INC (BCRX) insider trading

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Jon P Stonehouse

Director

—

1,460,419

$13.10M

+20.5%

Charles K Gayer

President and CCO

—

952,583

$8.54M

+205.5%

Alane P Barnes

Chief Legal Officer

—

400,703

$3.59M

+29.9%

Anthony Doyle

Chief Financial Officer

—

377,867

$3.39M

+41.2%

Helen M. Thackray

Chief R&D Officer

—

377,318

$3.38M

+38.6%

Babar Ghias

Chief Financial Officer

—

268,700

$2.41M

—

Sandeep Menon

Chief R&D Officer

—

205,150

$1.84M

—

Vincent Milano

Director

—

109,642

$983.49K

+45.5%

Nancy J Hutson

Director

—

99,138

$889.27K

+5.9%

Theresa Heggie

Director

—

80,646

$723.39K

+52.6%

Alan G Levin

Director

—

79,565

$713.70K

+53.7%

Amy E McKee

Director

—

47,821

$428.95K

+71.8%

Machelle Sanders

Director

—

45,936

$412.05K

+65.6%

Steven Frank

Director

—

36,747

$329.62K

—

Jill C. Milne

Director

—

33,226

$298.04K

—

Steven K Galson

Director

—

27,794

$249.31K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

BIOCRYST PHARMACEUTICALS INC

What the insiders did No buying or selling

By person